📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial. (2015)

First Author: White MT

Attributed to: MRC Centre for Outbreak Analysis and Modelling Renewal funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(15)00239-x

PubMed Identifier: 26342424

Publication URI: http://europepmc.org/abstract/MED/26342424

Type: Journal Article/Review

Volume: 15

Parent Publication: The Lancet. Infectious diseases

Issue: 12

ISSN: 1473-3099